LONDON — Jesy Nelson is back in the public eye, but the former Little Mix star’s return to headlines is being driven by something far more serious than a music release. After revealing that her twin daughters, Ocean Jade and Story Monroe, were diagnosed with spinal muscular atrophy, Nelson has become a prominent voice pushing to add SMA to the UK’s newborn heel-prick test, April 9, 2026.
The latest shift is real, but it is not complete. England is now moving toward screening for SMA through an in-service evaluation from October 2026, while Scotland has already become the first part of the UK to start screening newborns for the condition. That leaves Nelson’s campaign in an unusual position: it has helped intensify public pressure, but it is still pushing against a system that does not yet offer routine nationwide screening.
Why Jesy Nelson’s SMA campaign matters
According to the NHS, SMA is a rare genetic condition that causes muscle weakness and can affect movement, breathing and swallowing. The case for earlier testing is straightforward: treatment works best before symptoms take hold.
That is why this story has moved beyond celebrity news. On the live Parliament petition page, the push to add SMA to the newborn blood spot test had passed 149,000 signatures by Thursday and had already crossed the threshold to be considered for a debate in Parliament.
At the same time, the UK National Screening Committee’s current position still says SMA is not currently recommended for routine screening, even as its review and evaluation work continue. That tension explains why campaigners are treating every policy move as progress, but not a finish line.
Jesy Nelson and the newborn screening push
The newest breakthrough came when SMA UK said England’s in-service evaluation would begin screening for SMA from October 2026, earlier than previously expected. For families and clinicians, that is not a symbolic win. It means some babies should be diagnosed sooner, when treatment can still change the course of the disease.
Pressure is also growing from outside England. Scotland’s rollout has given campaigners a working UK example rather than a purely theoretical case.
Jesy Nelson’s campaign did not start this week
This moment makes more sense in a longer timeline. In December 2025, the UK National Screening Committee was already detailing laboratory, clinical and NHS planning for an SMA in-service evaluation. After sharing her daughters’ diagnosis, Nelson then told ITV News she felt a “duty of care” to raise awareness. By February, she had turned that message into a formal petition aimed at speeding up change.
That continuity matters. It shows this is not a one-cycle burst of celebrity advocacy. It is a campaign that moved from private diagnosis, to public testimony, to policy pressure and now to measurable movement inside the screening system.
What happens next for Jesy Nelson and the policy fight
The next question is whether October’s evaluation becomes a bridge to nationwide screening or another slow stage in a process families have already waited too long to navigate. Ministers have said the NHS is planning an in-service evaluation in England, and campaigners want that work to lead quickly to a permanent change rather than another round of delay.
For Nelson, the story has already gone beyond personal pain. Her daughters’ diagnosis has pushed a wider question into public view: if early detection can change a child’s life, pressure will only grow on officials to explain every further delay.
